BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Heart
,
Early pregnancy factor
,
Doxorubicin
,
rs6983267
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
D1 receptor
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Putamen
Accumbens
Caudate nucleus
Caudate
Superior cervical ganglion
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Huntington's disease
Ischemic reperfusion injury
Radiation injury
Nerve injury
Disorder of basal ganglia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
acetophenazine
Dopamine
Lisuride
Methylergonovine
Fenoldopam
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR21
Mir30b
MIRLET7D
SORD
CDK7
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Loss-of-Function Variants in DRD1 in Infantile Parkinsonism-Dystonia.
The selective dopamine D1 receptor agonist SKF81297 modulates NMDA receptor currents independently o…
Visualization of differential GPCR crosstalk in DRD1-DRD2 heterodimer upon different dopamine levels…
Dopamine D1 receptor in the NAc shell is involved in delayed emergence from isoflurane anesthesia in…
Dopamine D1 and D4 receptors contribute to light adaptation in ON-sustained retinal ganglion cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562
Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
A Study To Evaluate D1 Receptor Occupancy (RO) Following Single Dose of PF-06412562 In Healthy Male …
Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ